Japanese pharmaceutical giant Mitsubishi Tanabe Pharma Corp. announced that a COVID-19 vaccine derived from a type of tobacco ...
A plant-based Covid-19 vaccine developed by Canadian pharmaceutical firm Medicago “very likely won’t be accepted” for emergency use approval by the World Health Organization because Medicago is ...
Add Yahoo as a preferred source to see more of our stories on Google. An worker inspects the Nicotiana benthamiana plants at Medicago greenhouse in Quebec City (Reuters) - Canadian drug developer ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Biotechnology company Medicago (TSX:MDG) now has a facility that needs just 30 days to turn into new flu vaccine the plant that has been the cornerstone of North Carolina’s economy for hundreds of ...
Under the terms of the research collaboration, Medicago will apply its transient expression system to develop a vaccine candidate for a non-disclosed target. Medicago is eligible to receive payments ...
QUEBEC CITY, Quebec--(BUSINESS WIRE)--Medicago, a biopharmaceutical company headquartered in Quebec City, announced today that its vaccine candidate for COVID-19 induced a positive antibody response ...
Dynavax and Medicago Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate
EMERYVILLE, CA and QUEBEC CITY, CANADA / ACCESSWIRE / July 8, 2020 / Dynavax Technologies Corporation (DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, and ...
(Reuters) – Canadian drug developer Medicago said on Tuesday a combination of its experimental COVID-19 vaccine and GlaxoSmithKline’s vaccine booster produced virus-neutralizing antibodies in all ...
The first Canadian-made COVID-19 vaccine by Medicago has been rejected by the World Health Organization (WHO) due to its ties to tobacco giant Philip Morris. “We are aware that the WHO updated ...
Medicago is also planning a Phase 2/3 trial to be initiated this October. “ We are thrilled to see our COVID-19 vaccine candidate enter the Phase 1 trial, and we look forward to obtaining safety and ...
Medicago will be shutting down its COVID-19 vaccine project in Quebec after its sole shareholder decided to no longer invest in the company, the company announced Thursday. With the Japan-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results